GlassScriptPhysician profile
Mary Yates Codrick
NPI 1720783780
$2,253.72
in general payments reported to CMS, 2019-2025
14 companies · $678 in 2025
The $678 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $443 · 2024: $1,133 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,137 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.64 |
| Education | $117.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $627.02 | 2023-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $381.23 | 2024-2025 | Austedo Xr, Austedo Xr |
| Otsuka America Pharmaceutical, INC. | $207.81 | 2023-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Abbvie INC. | $197.89 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $188.87 | 2023-2024 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $149.02 | 2024 | Auvelity |
| Mdd US Operations, LLC | $113.96 | 2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $83.48 | 2023-2024 | Trintellix |
| Neurocrine Biosciences, INC. | $68.70 | 2023-2024 | Ingrezza |
| Alkermes, INC. | $58.41 | 2024-2025 | Lybalvi, Aristada |
| E.R. Squibb & Sons, L.L.C. | $55.17 | 2025 | Cobenfy |
| Supernus Pharmaceuticals, INC. | $51.58 | 2025 | Qelbree |
| Almatica Pharma LLC | $50.33 | 2023-2024 | Loreev Xr |
| Ironshore Pharmaceuticals INC. | $20.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Codrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.